Jennison Associates’s Insulet PODD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-70,117
| Closed | -$14.7M | – | 611 |
|
|
2026
Q1 | $14.7M | Sell |
70,117
-35,395
| -34% | -$8.9M | 0.01% | 350 |
|
|
2025
Q4 | $30M | Buy |
105,512
+5,656
| +6% | +$1.77M | 0.02% | 279 |
|
|
2025
Q3 | $30.8M | Sell |
99,856
-8,498
| -8% | -$2.66M | 0.02% | 286 |
|
|
2025
Q2 | $34M | Sell |
108,354
-133,363
| -55% | -$38.5M | 0.02% | 269 |
|
|
2025
Q1 | $63.5M | Buy |
241,717
+83,375
| +53% | +$22.6M | 0.04% | 178 |
|
|
2024
Q4 | $41.3M | Buy |
158,342
+28,375
| +22% | +$7.15M | 0.03% | 260 |
|
|
2024
Q3 | $30.2M | Buy |
129,967
+69,180
| +114% | +$14.2M | 0.02% | 299 |
|
|
2024
Q2 | $12.3M | Sell |
60,787
-19,200
| -24% | -$3.46M | 0.01% | 367 |
|
|
2024
Q1 | $13.7M | Sell |
79,987
-127,532
| -61% | -$23.8M | 0.01% | 372 |
|
|
2023
Q4 | $45M | Buy |
207,519
+75,954
| +58% | +$13M | 0.03% | 218 |
|
|
2023
Q3 | $21M | Buy |
131,565
+833
| +0.6% | +$187K | 0.02% | 310 |
|
|
2023
Q2 | $37.7M | Buy |
130,732
+11,391
| +10% | +$3.46M | 0.03% | 233 |
|
|
2023
Q1 | $38.1M | Buy |
119,341
+21,555
| +22% | +$6.39M | 0.03% | 225 |
|
|
2022
Q4 | $28.8M | Buy |
97,786
+17,024
| +21% | +$4.7M | 0.03% | 275 |
|
|
2022
Q3 | $18.5M | Buy |
+80,762
| New | +$20.2M | 0.02% | 325 |
|
|
2021
Q3 | – | Sell |
-63,536
| Closed | -$17.4M | – | 712 |
|
|
2021
Q2 | $17.4M | Sell |
63,536
-191,044
| -75% | -$51.9M | 0.01% | 390 |
|
|
2021
Q1 | $66.4M | Buy |
254,580
+13,185
| +5% | +$3.53M | 0.05% | 179 |
|
|
2020
Q4 | $61.7M | Sell |
241,395
-23,613
| -9% | -$5.86M | 0.04% | 173 |
|
|
2020
Q3 | $62.7M | Buy |
265,008
+102,907
| +63% | +$21.7M | 0.05% | 147 |
|
|
2020
Q2 | $31.5M | Buy |
162,101
+49,917
| +44% | +$9.54M | 0.03% | 232 |
|
|
2020
Q1 | $18.6M | Buy |
112,184
+38,605
| +52% | +$7.05M | 0.02% | 266 |
|
|
2019
Q4 | $12.6M | Sell |
73,579
-135,617
| -65% | -$22.6M | 0.01% | 362 |
|
|
2019
Q3 | $34.5M | Sell |
209,196
-74,621
| -26% | -$10.5M | 0.04% | 239 |
|
|
2019
Q2 | $33.9M | Buy |
283,817
+98,995
| +54% | +$10.1M | 0.03% | 268 |
|
|
2019
Q1 | $17.6M | Buy |
184,822
+102,002
| +123% | +$8.74M | 0.02% | 377 |
|
|
2018
Q4 | $6.57M | Buy |
82,820
+79,234
| +2,210% | +$6.71M | 0.01% | 466 |
|
|
2018
Q3 | $380K | Buy |
+3,586
| New | +$336K | ﹤0.01% | 648 |
|
|
2017
Q1 | – | Sell |
-7,636
| Closed | -$288K | – | 763 |
|
|
2016
Q4 | $288K | Buy |
7,636
+484
| +7% | +$18K | ﹤0.01% | 740 |
|
|
2016
Q3 | $293K | Sell |
7,152
-7,970
| -53% | -$315K | ﹤0.01% | 635 |
|
|
2016
Q2 | $457K | Buy |
+15,122
| New | +$470K | ﹤0.01% | 606 |
|
|
2015
Q2 | – | Sell |
-9,456
| Closed | -$315K | – | 758 |
|
|
2015
Q1 | $315K | Sell |
9,456
-32,383
| -77% | -$1.09M | ﹤0.01% | 702 |
|
|
2014
Q4 | $1.93M | Sell |
41,839
-26,428
| -39% | -$1.13M | ﹤0.01% | 595 |
|
|
2014
Q3 | $2.52M | Sell |
68,267
-22,600
| -25% | -$825K | ﹤0.01% | 559 |
|
|
2014
Q2 | $3.6M | Buy |
90,867
+693
| +0.8% | +$26.6K | ﹤0.01% | 528 |
|
|
2014
Q1 | $4.28M | Sell |
90,174
-458,506
| -84% | -$20.3M | ﹤0.01% | 524 |
|
|
2013
Q4 | $20.4M | Sell |
548,680
-1,455,527
| -73% | -$53.8M | 0.02% | 446 |
|
|
2013
Q3 | $72.6M | Sell |
2,004,207
-294,507
| -13% | -$9.88M | 0.08% | 235 |
|
|
2013
Q2 | $72.2M | Buy |
+2,298,714
| New | +$65.1M | 0.08% | 233 |
|
Other funds holding PODD
Jennison Associates's PODD Position: Q2 2026 in Review
Jennison Associates sold out of Insulet (PODD) in Q2 2026, closing a stake of 70,117 shares — an estimated $14.7M sold.
Jennison Associates first reported a position in PODD in Q2 2013 and held it in 38 quarters. The position peaked at $72.6M in Q3 2013. 726 funds tracked by Wall St. Rank hold PODD as of Q2 2026.
- Jennison Associates reported no remaining Insulet position as of Q2 2026 after selling out during the quarter.
- Jennison Associates sold 70,117 Insulet shares in Q2 2026, an estimated $14.7M.
- Jennison Associates first reported a position in Insulet in Q2 2013 and held it in 38 quarters.
- Jennison Associates's Insulet position peaked at $72.6M in Q3 2013.
- 726 funds tracked by Wall St. Rank held Insulet as of Q2 2026.
Based on Jennison Associates's 13F filing for Q2 2026, filed 3 Aug 2026.